Exo Therapeutics Competitors and Similar CompaniesClear all

Exo Therapeutics's competitors and similar companies include Walvax Biotechnology, Serum Institute of India, The Searle Company and Shandong Saito Biotechnology.
Exo Therapeutics
Exo Therapeutics
Exo Therapeutics is a company engaged in molecule drug discovery and development.
Walvax Biotechnology
Walvax Biotechnology
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
Serum Institute of India
Serum Institute of India
Serum Institute of India is a biotechnology company.
The Searle Company
The Searle Company
The Searle Company is a pharmaceutical company.
Shandong Saito Biotechnology
Shandong Saito Biotechnology
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
Founding Date
Founding Date
2018
Founding Date
2001
Founding Date
1966
Founding Date
1965
Founding Date
2010
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Kunming, CN HQ
Locations
Pune, IN HQ
Mumbai, IN
Pune, IN
Locations
Karachi, PK HQ
Karachi, PK
Karachi, PK
Lahore, PK
Locations
Heze, CN HQ
Employees
Employees
186% increase
Employees
2,388
Employees
5,3831% increase
Employees
2,4241% increase
Employees
95920% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.3 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
708.6 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥2.4b (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
¥961.3m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
¥615.2m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥864.3m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
¥1.8b (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
¥140.3m (FY, 2025)
Net income
Net income
N/A
Net income
¥125.2m (FY, 2025)
Net income
N/A
Net income
N/A
Net income
(¥84.7m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 103m
Total funding raised
$ 72.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388

Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.

View company
Serum Institute of India
HQ
Pune, IN

Serum Institute of India is a biotechnology company.

View company
The Searle Company
HQ
Karachi, PK
Employees
2,424↑ 1% increase

The Searle Company is a pharmaceutical company.

View company
Shandong Saito Biotechnology
HQ
Heze, CN
Employees
959↓ 20% decrease

Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.

View company